Valuation: Implanet SA

Market Cap 24.02M 27.65M 22.3M 20.57M 38.75M 2.64B 39.45M 264M 103M 1.31B 104M 102M 4.41B P/E 2024
-2.85x
P/E 2025 -5.8x
Enterprise Value 26.93M 31.01M 25.01M 23.07M 43.45M 2.96B 44.23M 296M 116M 1.47B 116M 114M 4.94B EV / Sales 2024
2x
EV / Sales 2025 2.23x
Free-Float
33.85%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2012-11-26
Director of Finance/CFO - 2015-08-31
Chief Operating Officer - -
Director TitleAgeSince
Chairman 71 2011-04-05
Director/Board Member - 2013-01-21
Director/Board Member - 2014-06-09
Change 5-day change 1-year change 3-year change Capi.($)
-2.86%-6.85% - - 27.33M
-1.20%+9.11%-13.08%+22.80% 135B
-2.18%+6.17%+0.68%-0.04% 13.57B
+4.24%+10.77%+79.18%+118.46% 9.49B
+3.30%-0.92%-42.64%-68.82% 4.65B
-0.52%+0.84%-0.20%+37.81% 2.68B
-3.17%+12.43%+8.40%-54.15% 1.74B
-0.99%+1.14%-18.51%-24.14% 1.67B
+0.30%+2.64%-26.45%-33.09% 1.65B
Average -0.33%+7.30%-1.58%-0.15% 21.31B
Weighted average by Cap. -0.84%+9.57%-7.41%+22.26%

Financials

2024 2025
Net sales 9.41M 10.83M 8.73M 8.06M 15.17M 1.03B 15.45M 103M 40.49M 513M 40.67M 39.78M 1.73B 12.47M 14.36M 11.58M 10.68M 20.12M 1.37B 20.49M 137M 53.69M 681M 53.93M 52.75M 2.29B
Net income -4.37M -5.03M -4.05M -3.74M -7.04M -480M -7.17M -48M -18.79M -238M -18.88M -18.46M -801M -4.38M -5.04M -4.07M -3.75M -7.07M -482M -7.2M -48.18M -18.86M -239M -18.95M -18.53M -804M
Net Debt 4.57M 5.26M 4.24M 3.91M 7.37M 502M 7.5M 50.23M 19.67M 249M 19.75M 19.32M 839M 2.92M 3.36M 2.71M 2.5M 4.7M 320M 4.79M 32.05M 12.55M 159M 12.6M 12.33M 535M
Logo Implanet SA
Implanet SA designs, produces, and sells medical implants and devices used in orthopedic surgery. The group's products include spinal bracing systems, intersomatic cages, pins, suture threads, screws, anchors, etc. Net sales break down by activity as follows: - sale of implants and devices for spinal surgery (68.6%); - distribution of medical equipment (31.3%). Net sales are distributed geographically as follows: France (35.6%), the United States (30.8%) and other (33.6%).
Employees
-